Tenaya Therapeutics
TNYA
88 hedge funds and large institutions have $62.8M invested in Tenaya Therapeutics in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 28 closing their positions.
53% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 19
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
7% less funds holding
Funds holding: 95 → 88 (-7)
17% less call options, than puts
Call options by funds: $266K | Put options by funds: $321K
17.55% less ownership
Funds ownership: 73.05% → 55.51% (-18%)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
43% less capital invested
Capital invested by funds: $111M → $62.8M (-$48.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$11.5M |
| 2 |
BlackRock
New York
|
+$2.67M |
| 3 |
Morgan Stanley
New York
|
+$2.63M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.01M |
| 5 |
MG
Marex Group
London,
|
+$588K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$13.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.48M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$4.97M |
| 4 |
IHAM
Integral Health Asset Management
New York
|
-$4.58M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.25M |
TNYA Hedge Fund Activity: Q4 2024 in Review
88 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q4 2024, worth a combined $62.8M — down 43% from $111M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of TNYA and 22 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 29 added.
The largest buyer was JP Morgan Chase, adding an estimated $11.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $13.5M sold.
- 88 institutional investors held Tenaya Therapeutics (TNYA) as of Q4 2024, down from 95 in Q3 2024.
- Funds reported $62.8M of Tenaya Therapeutics stock for Q4 2024, down 43% quarter-over-quarter.
- 22 funds opened new Tenaya Therapeutics positions in Q4 2024 and 28 closed out, a net change of -6 holders.
- The largest Tenaya Therapeutics buyer in Q4 2024 was JP Morgan Chase, an estimated $11.5M added.
- The largest Tenaya Therapeutics seller in Q4 2024 was RA Capital Management, an estimated $13.5M sold.
Based on aggregated 13F filings for Q4 2024.